BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15190106)

  • 1. Hypocretinergic control of spinal cord motoneurons.
    Yamuy J; Fung SJ; Xi M; Chase MH
    J Neurosci; 2004 Jun; 24(23):5336-45. PubMed ID: 15190106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State-dependent control of lumbar motoneurons by the hypocretinergic system.
    Yamuy J; Fung SJ; Xi M; Chase MH
    Exp Neurol; 2010 Feb; 221(2):335-45. PubMed ID: 19962375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin/orexin neurons.
    Acuna-Goycolea C; Li Y; Van Den Pol AN
    J Neurosci; 2004 Mar; 24(12):3013-22. PubMed ID: 15044540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocretinergic facilitation of synaptic activity of neurons in the nucleus pontis oralis of the cat.
    Xi MC; Fung SJ; Yamuy J; Morales FR; Chase MH
    Brain Res; 2003 Jun; 976(2):253-8. PubMed ID: 12763260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of the cat.
    Xi MC; Fung SJ; Yamuy J; Morales FR; Chase MH
    J Neurophysiol; 2002 Jun; 87(6):2880-8. PubMed ID: 12037191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons.
    Li Y; van den Pol AN
    J Neurosci; 2005 Jan; 25(1):173-83. PubMed ID: 15634779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocretin-1 causes G protein activation and increases ACh release in rat pons.
    Bernard R; Lydic R; Baghdoyan HA
    Eur J Neurosci; 2003 Oct; 18(7):1775-85. PubMed ID: 14622212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral hypothalamus: early developmental expression and response to hypocretin (orexin).
    Van Den Pol AN; Patrylo PR; Ghosh PK; Gao XB
    J Comp Neurol; 2001 May; 433(3):349-63. PubMed ID: 11298360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between hypocretinergic and GABAergic systems in the control of activity of neurons in the cat pontine reticular formation.
    Xi M; Fung SJ; Yamuy J; Chase MH
    Neuroscience; 2015 Jul; 298():190-9. PubMed ID: 25892701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal.
    Acuna-Goycolea C; van den Pol A
    J Neurosci; 2004 Sep; 24(37):8141-52. PubMed ID: 15371515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct excitation of hypocretin/orexin cells by extracellular ATP at P2X receptors.
    Wollmann G; Acuna-Goycolea C; van den Pol AN
    J Neurophysiol; 2005 Sep; 94(3):2195-206. PubMed ID: 15958604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin-2 receptors inhibit primary afferent fiber-evoked responses of ventral roots in the neonatal rat isolated spinal cord.
    Shono K; Yamamoto T
    Brain Res; 2008 Jul; 1218():97-102. PubMed ID: 18511021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: a double-labeling immunohistochemical study.
    Fung SJ; Yamuy J; Sampogna S; Morales FR; Chase MH
    Brain Res; 2001 Jun; 903(1-2):257-62. PubMed ID: 11382413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.
    LeSage MG; Perry JL; Kotz CM; Shelley D; Corrigall WA
    Psychopharmacology (Berl); 2010 Apr; 209(2):203-12. PubMed ID: 20177882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area.
    Bartsch T; Levy MJ; Knight YE; Goadsby PJ
    Pain; 2004 Jun; 109(3):367-378. PubMed ID: 15157698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response.
    Winsky-Sommerer R; Yamanaka A; Diano S; Borok E; Roberts AJ; Sakurai T; Kilduff TS; Horvath TL; de Lecea L
    J Neurosci; 2004 Dec; 24(50):11439-48. PubMed ID: 15601950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.
    van den Pol AN; Gao XB; Obrietan K; Kilduff TS; Belousov AB
    J Neurosci; 1998 Oct; 18(19):7962-71. PubMed ID: 9742163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a subpopulation of orexin/hypocretin-containing hypothalamic neurons by GABAA receptor-mediated inhibition of the nucleus accumbens shell, but not by exposure to a novel environment.
    Baldo BA; Gual-Bonilla L; Sijapati K; Daniel RA; Landry CF; Kelley AE
    Eur J Neurosci; 2004 Jan; 19(2):376-86. PubMed ID: 14725632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity.
    Gompf HS; Aston-Jones G
    Brain Res; 2008 Aug; 1224():43-52. PubMed ID: 18614159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
    Rasmussen K; Hsu MA; Yang Y
    Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.